In situ analysis of transforming growth factors-β (TGF-β1, TGF-β2, TGF-β3) and TGF-β type II receptor expression in basal cell carcinomas

British Journal of Dermatology

Volumn 134, Issue 6, 1996, Pages 1044-1051

  Schmid, P ^a   Itin, P ^a   Rufli, T H ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0029941913     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07940.x     Document Type: Article

References (30)

1. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 1993: 8: 1-9.
2. Wahl S. Transforming growth factor β: the good, the bad, and the ugly. J Exp Med 1994: 180: 1587-90.
3. Wrana JL, Attisano L, Wieser R et al. Mechanism of activation of the TGF-β receptor. Nature 1994: 370: 341-7.
4. Shipley GD, Pittelkow MR, Wille JJ et al. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum free medium. Cancer Res 1986: 46: 2068-71.
5. Mansbridge JN, Hanawalt PC. Role of transforming growth factor-beta in the maturation of human epidermal keratinocytes. J Invest Dermatol 1988: 90: 336-41.
6. Stamp GWH, Nashim M, Gardillo M et al. Transforming growth factor-β distribution in basal cell carcinomas: relationship to proliferation index. Br J Dermatol 1993: 129: 57-64.
7. Schmid P, Itin P, Rufli T. In situ analysis of transforming growth factor-βs (TGF-β1, TGF-β2, TGF-β3), and TGF-β type I receptor expression in malignant melanoma. Carcinogenesis 1995: 16: 1499-1503.
8. Schmid P, Cox D, Bilbe G et al. Differential expression of TGF-β1, β2, and β3 genes during mouse embryogenesis. Development 1991; 111: 117-30.
9. Pinto JS, Dobson MC, Dobson RL. The dermal response to carcinogens. In: Advances in Biology of the Skin. (Montagna W, Bentley JP, Dobson RL. eds). New York: Appleton-Century-Crofts. 1970: 195-220.
10. Flaxman AB. Growth in vitro and induction of differentiation in cells of basal cell cancer. Cancer Res 1972: 32: 462-8.
11. Roberts AB, Sporn MB. Differential expression of TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev 1992: 32: 91-8.
12. Schmid P, Kunz S, Cerletti N et al. Injury induced expression of TGF-β1 mRNA is enhanced by exogenously applied TGF-βs. Biochem Biophys Res Commun 1993: 194: 399-406.
13. Kane CJM, Hebda PA, Mansbridge JN, Hanawalt PC. Direct evidence for spatial and temporal regulation of transforming growth factor β1 expression during cutaneous wound healing. J Cell Physiol 1991: 148: 157-73.
14. Desmouliere AA, Geinoz F, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent growth cultured fibroblasts. J Cell Biol 1993; 122: 103-11.
15. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
16. Gailit J, Welch MP, Clark RAF. TGF-β1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol 1994; 103: 221-7.
17. Massaque J. The transforming growth factor-β family. Annu Rev Cell Biol 1990: 6: 597-641.
18. Gray JD, Hirokawa M, Horwitz DA. The role of transforming growth factor β in the generation of suppression: an interaction between CD8+ and NK cells. J Exp Med 1994: 180: 1937-42.
19. Rook AH, Kehrl JH, Wakefield LM et al. Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986; 136: 3916-20.
20. Grob JJ, Collet AM, Munoz MH, Bonerandi JJ. Treatment of large basal cell carcinomas with intralesional alpha-2a interferon. Lancet 1988: i: 878-9.
21. Büchner SA. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression. J Am Acad Dermatol 1991: 24: 731-4.
22. Park K, Kim S-J, Bang Y-J et al. Ginetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 1994: 91: 8772-6.
23. Schmid P, Cox D, Bilbe G et al. TGF-βs and TGF-β type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol 1994: 171: 191-7.
24. Graycar JL, Miller DA, Arrick BA et al. Human transforming growth factor-β3: recombinant expression, purification, and biological activities in comparison with transforming growth factor-β1 and -β2. Mol Endocrinol 1989: 3: 1977-86.
25. Escherick JS, DiCunto F, Flanders KC et al. Transforming growth factor β2 and β3 down-modulation in 12-o-tetradecanoylphorbol-13-acetate induced skin hyperplasia. Cancer Res 1993: 53: 5517-22.
26. Roberts AB, Thompson NL, Heien U et al. Transforming growth factor-β: possible roles in carcinogenesis. Br J Cancer 1988: 57: 594-600.
27. Welch DR, Fabra A, Nakajiama M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 1990: 87: 7678-82.
28. Torre Aminone G, Beauchamp RD, Koeppen H et al. Highly immunogenic tumor transfected with a murine transforming growth factor β1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 1990: 87: 1486-90.
29. Gorsch SM, Memoli VA, Stukel TA et al. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res 1992: 52: 6949-52.
30. Friess H, Yamanaka Y, Büchler M et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993: 105: 1846-56.